Dongsung Pharm Cash Flow Reinvestment Rate
Dongsung Pharm cash flow reinvestment rate. Dongsung Pharm (002210) has a Cash Flow Reinvestment Rate of 0.25x as of June 2025, reinvesting ₩1.07 Billion (capex ₩0.00 plus investments ₩-1.07 Billion) from operating cash flow of ₩4.20 Billion. Explore Dongsung Pharm (002210) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Dongsung Pharm (2010–2020)
Cash flow reinvestment rate of Dongsung Pharm from 2010 to 2020. Historical reinvestment intensity for Dongsung Pharm across 4 annual periods. Explore 002210 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Dongsung Pharm Cash Flow Reinvestment Rate by Year (2010–2020)
Dongsung Pharm cash flow reinvestment rate by year from 2010 to 2020. Year-by-year capital reinvestment analysis for Dongsung Pharm. For the full cash flow conversion analysis, see cash efficiency ratio of Dongsung Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.51x | ₩12.56 Billion | ₩5.01 Billion | ₩6.92 Billion | ▼ -83.5% |
| 2018 | 15.21x | ₩21.19 Billion | ₩1.39 Billion | ₩2.13 Billion | ▲ +668.2% |
| 2017 | 1.98x | ₩3.56 Billion | ₩1.80 Billion | ₩3.00 Billion | ▲ +588.0% |
| 2010 | 0.29x | ₩1.06 Billion | ₩3.68 Billion | ₩847.33 Million | — |